Gene Knowledge Graph
UTC

Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

hematocrit (maximum, inv-norm transformed)

KIF1B · rs147613335

Stands on its own. Nothing else here links to this position yet — but the page above is the point: what the research found, what each genotype means, and where it came from, in language you can read. Links to conditions, drugs and the senses appear automatically if we write them.

Strength of the evidence

1 / 4

Its strongest genetic-study result is p = 10−13, with 2 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 114,986 African American or Afro-Caribbean individuals, 55,837 Hispanic or Latin American individuals, 5,964 East Asian ancestry individuals, 407,836 European ancestry individuals.

The effect Each copy of the C allele shifted the measure 0.0274 lower (95% confidence interval 0.02-0.035); p = 8 × 10−14.

How common The C allele had a frequency of about 86% in the people studied.

Where it sits Chromosome 1, band 1p36.22 — in an intron of KIF1B.

How common each version is

CT
Korean KRGDB
C 99.8% · T 0.2%
Korean Korea4K
C 99.8% · T 0.2%
Korean Korea1K
C 99.7% · T 0.3%
Japanese ToMMo
C 98.4% · T 1.6%
World gnomAD
C 86.2% · T 13.8%
World 1000 Genomes
C 86.4% · T 13.6%
World TOPMed
C 86.1% · T 13.9%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study.

What each result means

C/C Two copies of the version the research linked to hematocrit (maximum, inv-norm transformed). That is the strongest link of the three results. A link in a study is not a diagnosis.
C/T One copy of the version the research linked to hematocrit (maximum, inv-norm transformed). That is a smaller link than two copies.
T/T No copy of the version the research linked to hematocrit (maximum, inv-norm transformed). This is the starting point the study compared everyone against.
Source
Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program
Verma A, Huffman JE, Rodriguez A, Conery M, Liu M, Ho YL, Kim Y, Heise DA, Guare L, Panickan VA, Garcon H, Linares F
and 59 more — show all
Costa L, Goethert I, Tipton R, Honerlaw J, Davies L, Whitbourne S, Cohen J, Posner DC, Sangar R, Murray M, Wang X, Dochtermann DR, Devineni P, Shi Y, Nandi TN, Assimes TL, Brunette CA, Carroll RJ, Clifford R, Duvall S, Gelernter J, Hung A, Iyengar SK, Joseph J, Kember R, Kranzler H, Kripke CM, Levey D, Luoh SW, Merritt VC, Overstreet C, Deak JD, Grant SFA, Polimanti R, Roussos P, Shakt G, Sun YV, Tsao N, Venkatesh S, Voloudakis G, Justice A, Begoli E, Ramoni R, Tourassi G, Pyarajan S, Tsao P, O'Donnell CJ, Muralidhar S, Moser J, Casas JP, Bick AG, Zhou W, Cai T, Voight BF, Cho K, Gaziano JM, Madduri RK, Damrauer S, Liao KP
Science (New York, N.Y.) · 2024 · PMID 39024449 · open access

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

hematocrit (maximum, inv-norm transformed) (rs147613335). MyGeneLog™. https://www.mygenelog.com/variants/rs147613335

← See all variants